Beyond the Cough: Recognizing, Diagnosing, and Managing the Invisible Burden of Refractory Chronic Cough

Learning Theater 3
Sponsored by: GSK

---

Program Description

Refractory chronic cough (RCC) is a distinct disease identified in a subset of people who experience a chronic cough (lasting >8 weeks) that persists despite thorough investigation and adequate treatment for cough-related etiologies. Research has demonstrated that RCC may be caused by neuronal hypersensitivity, which is driven by the dysregulation of cough signaling components.

RCC can profoundly affect a person’s quality of life, causing not only physical discomfort, but disruption of both their social life and work. The pathway to diagnosis of RCC is complex and often lengthy, as it often involves numerous specialist visits, prolonged diagnostic testing, and trials of treatments.

Enhanced awareness may support earlier identification and diagnosis of people living with RCC. Come join GSK Medical to learn more about the burden of RCC as a disease, including gaps in care, how to recognize it in the clinic, and steps to diagnosis, at our activities at our activities at CHEST 2025:

• Symposium presentation at Learning Theater 3 on Monday, October 20^th from 2:30-3:15 PM for our multidisciplinary expert panel, “Beyond the Cough: Recognizing, Diagnosing, and Managing the Invisible Burden of Refractory Chronic Cough.” Through expert insights and patient-centric perspectives, specialists will discuss the barriers to recognition of RCC, the burden of RCC on individuals, and identify opportunities for improved diagnosis and management.
• GSK Medical Booth #1802 – You can take a turn at the wheel and explore the path to diagnosis in our RCC Raceway arcade. You can watch a video to learn more about the mechanism of disease and meet Neville the nerve.

The symposium is a non-CME event and does not qualify for CME, CE, or MOC credit. The symposium is not part of the official CHEST Annual Meeting 2025 conference sessions. The symposium is not an endorsement by CHEST and does not reflect the views or opinions of CHEST.

All materials are sponsored by GSK, are non-promotional in nature, and for US Healthcare professionals only.

PSE-US-4318; August 2025.

Presenters

Rachel Taliercio, DO
Integrated Hospital-Care Institute
Safety Quality and Patient Experience, Respiratory Medicine
Vice Chair
Cleveland, Ohio

Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Assistant Professor
Cleveland, Ohio

Michael S. Blaiss, MD, FACAAI, FAAAAI
Medical College of Georgia at Augusta University
Clinical Professor
Augusta, Georgia